The Maryland Stem Cell Research Commission announced Monday it will grant$7,067,409in award funding to innovative research that will strengthen and advance stem cell treatments and technologies inMaryland.

Awardees submitted proposals to the Commission in response to its Request for Applications (RFAs) for its second round of funding cycle in 2022.

Recipients include 24 scientists accelerating research atJohns Hopkins University, Britecyte, Inc., RenOVAte Biosciences, Inc., RoosterBio, Inc., and theUniversity of Maryland, Baltimore.

The Commission has also issued a RFAs for its first round of funding for fiscal year 2023 and is looking to continue accelerating cutting-edge research and cures through theMaryland Stem Cell Research Fund (MSCRF).

Established under the Maryland Stem Cell Research Act of 2006, MSCRF promotes state-funded stem cell research and cures through grants to both public and private entities inMaryland. MSCRF has a current budget of$20.5 millionfor FY2023.

See the original post here:

Md. Stem Cell Research Commission awards more than $7M - Maryland Daily Record

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh